Recombinant Human GNRH1 Protein: Research Use Guidelines

Recombinant Human GNRH1 Protein is a biologically relevant research tool representing the key hypothalamic decapeptide that drives pituitary gonadotropin secretion, enabling scientists to investigate reproductive endocrinology, receptor signaling, and related therapeutic targets in vitro and in vivo.

Product Name

Recombinant Human GNRH1 Protein

SKU

rp368024

Protein Origin

Human (Homo sapiens) GNRH1 sequence

Protein Class

Recombinant neuropeptide / gonadotropin-releasing hormone

Primary Research Area

Reproductive endocrinology, neuroendocrinology, receptor pharmacology

Recommended Storage

Store lyophilized protein at -20 °C or -80 °C; avoid repeated freeze-thaw cycles

Intended Use

For research use only (RUO); not for diagnostic or therapeutic use

Background: GNRH1 Biology and Research Significance

Gonadotropin-releasing hormone 1 (GNRH1), also known as luteinizing hormone-releasing hormone (LHRH), is a decapeptide produced by hypothalamic neurons and released in a pulsatile manner into the hypothalamic–pituitary portal circulation. Upon binding to the GNRH receptor (GNRHR) on gonadotroph cells of the anterior pituitary, GNRH1 stimulates the synthesis and secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn regulate gonadal steroidogenesis and gametogenesis.

GNRH1 signaling is central to the hypothalamic–pituitary–gonadal (HPG) axis and is implicated in puberty onset, reproductive cyclicity, fertility regulation, and sex hormone-dependent cancers. Recombinant Human GNRH1 Protein (rp368024) provides researchers with a well-defined, human-sequence reagent to study receptor binding kinetics, downstream intracellular signaling cascades (including IP3/DAG and MAPK pathways), and the development of GNRH analogues for clinical translation.

Reconstitution and Handling Protocol

Materials required: Sterile deionized water or manufacturer-recommended reconstitution buffer, low-protein-binding microcentrifuge tubes, and sterile pipette tips.

1. Equilibrate to room temperature: Allow the vial to equilibrate to room temperature (18–25 °C) for approximately 10 minutes before opening to minimize condensation and protein aggregation upon reconstitution.
2. Reconstitution: Reconstitute the lyophilized protein by adding the appropriate volume of sterile deionized water or the buffer specified on the product datasheet to achieve the desired working concentration. Gently swirl or pipette; do not vortex vigorously to avoid denaturation.
3. Carrier protein addition (optional): To enhance stability in dilute solutions, consider adding a carrier protein such as 0.1% bovine serum albumin (BSA, research grade) to the reconstitution buffer.
4. Centrifuge: Briefly centrifuge the vial (1,000–2,000 × g, 30 seconds) to collect any material adhering to the cap or walls before opening.
5. Aliquot immediately: Prepare single-use aliquots to avoid repeated freeze-thaw cycles, which can degrade peptide integrity and reduce biological activity.

Note: Always consult the product-specific Certificate of Analysis (CoA) for lot-specific reconstitution instructions and confirmed protein concentration.

Storage, Stability, and Quality Specifications

Storage conditions:

• Lyophilized form: Store at -20 °C for routine use or at -80 °C for long-term archival storage. Lyophilized protein is generally stable for up to 12 months when stored correctly, though lot-specific expiry should be confirmed on the CoA.
• Reconstituted protein: Once reconstituted, aliquots may be stored at -80 °C. Avoid storing reconstituted protein at 4 °C for extended periods as peptide degradation may occur.
• Freeze-thaw cycles: Limit to a maximum of 2–3 freeze-thaw cycles. Repeated freeze-thaw events can cause aggregation, loss of bioactivity, and inaccurate concentration measurements.

Quality specifications to verify on CoA:

• Purity: Assessed by SDS-PAGE or HPLC (target purity level as specified per lot).
• Biological activity: Confirmed by cell-based or receptor-binding assays where applicable.
• Endotoxin level: Verified by LAL assay to ensure suitability for cell-based assays.
• Identity: Confirmed by mass spectrometry or N-terminal sequencing.

All specifications are lot-dependent; refer to the supplied CoA for confirmed values.

Recommended Research Applications

Recombinant Human GNRH1 Protein (rp368024) is suitable for a range of in vitro and in vivo research applications, including but not limited to:

• Receptor binding and competition assays: Use as a reference ligand to characterize GNRHR affinity and pharmacological competition with GNRH analogues or antagonists.
• Cell signaling studies: Stimulate GNRHR-expressing cell lines (e.g., pituitary gonadotroph models, transfected HEK293 cells) to investigate downstream pathways including PKC activation, MAPK phosphorylation, and gonadotropin gene expression.
• Gonadotropin secretion studies: Use in primary pituitary cell cultures or ex vivo systems to measure LH and FSH release in response to GNRH1 stimulation.
• Cancer biology: Investigate GNRHR expression and GNRH1 effects in hormone-sensitive tumor cell lines (e.g., prostate, breast, ovarian cancer models) where autocrine/paracrine GNRH signaling has been reported.
• Drug discovery and analogue development: Serve as a positive control or reference standard when screening novel GNRH agonists or antagonists for reproductive medicine applications.
• Assay development and validation: Use as a standard or calibrator in ELISA, radioimmunoassay (RIA), or other quantitative assays measuring GNRH1 levels.

Troubleshooting Common Issues

The following table outlines common challenges encountered when working with Recombinant Human GNRH1 Protein and recommended corrective actions:

• No or low biological activity: Confirm protein was reconstituted and stored correctly. Check that freeze-thaw cycles have not exceeded recommended limits. Verify cell model expresses functional GNRHR. Ensure assay conditions (pH, temperature, serum-free medium) are appropriate.
• Protein aggregation or precipitation: Ensure reconstitution buffer is at the correct pH and ionic strength. Avoid vigorous vortexing. Add carrier protein (0.1% BSA) to stabilize dilute solutions. Use low-protein-binding tubes and tips.
• Inconsistent results between lots: Always perform lot-to-lot comparison using an internal reference standard. Review CoA for lot-specific purity and activity data. Titrate each new lot in your assay system.
• High background in cell-based assays: Test for endotoxin contamination using LAL assay if not pre-validated. Use endotoxin-free reconstitution buffers and consumables.
• Rapid activity loss during experiment: Keep reconstituted aliquots on ice during use. Minimize exposure to room temperature. Avoid repeated pipetting from the same aliquot.

Frequently asked questions

What is the recommended reconstitution buffer for Recombinant Human GNRH1 Protein (rp368024)?

Sterile deionized water is commonly used for initial reconstitution of lyophilized GNRH1 protein. The product-specific Certificate of Analysis (CoA) should always be consulted for lot-confirmed reconstitution recommendations. Adding 0.1% BSA to the working buffer can improve stability at low concentrations.

How many freeze-thaw cycles can Recombinant Human GNRH1 Protein withstand without significant loss of activity?

It is generally recommended to limit freeze-thaw cycles to a maximum of 2–3 times. To minimise exposure to repeated freeze-thaw events, prepare single-use aliquots immediately after reconstitution and store them at -80 °C until required.

Is Recombinant Human GNRH1 Protein (rp368024) suitable for in vivo animal studies?

This product is designated For Research Use Only (RUO) and is not approved for diagnostic or therapeutic use. Suitability for in vivo studies depends on lot-specific endotoxin levels and formulation; always verify endotoxin content on the CoA and conduct appropriate animal ethics review before proceeding with in vivo experiments.

How can I confirm the biological activity of a new lot of Recombinant Human GNRH1 Protein?

Biological activity is typically confirmed by a cell-based assay, such as measuring IP1 accumulation or LH release in GNRHR-expressing cells following GNRH1 stimulation. The CoA will indicate whether activity testing was performed and provide the ED50 or specific activity value for that lot. Comparing with a previously validated internal reference standard is also recommended.

What cell lines are commonly used to study GNRH1 receptor signaling with this protein?

Commonly used model systems include primary pituitary gonadotroph cultures, the LβT2 mouse gonadotroph cell line, and heterologous expression systems such as HEK293 cells stably or transiently transfected with human GNRHR. Certain cancer cell lines (e.g., LNCaP for prostate cancer, MCF-7 for breast cancer) that endogenously express GNRHR are also used in oncology-focused GNRH1 research.

References

1. Millar RP. GnRHs and GnRH receptors. Animal Reproduction Science. 2005;88(1-2):5-28.
2. Conn PM, Crowley WF Jr. Gonadotropin-releasing hormone and its analogs. Annual Review of Medicine. 1994;45:391-405.
3. Flanagan CA. Receptor conformation and constitutive activity in GnRH receptor signalling. Molecular and Cellular Endocrinology. 2010;320(1-2):1-9.
4. Aladdin Scientific. Recombinant Human GNRH1 Protein (rp368024) Certificate of Analysis. Aladdin Scientific; [lot-specific].

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.